Trang chủ › Ung thư tuyến tiền liệt › Massachusetts › Boston
Thử nghiệm lâm sàng cho Ung thư tuyến tiền liệt tại Boston, MA
56 nghiên cứu cho Ung thư tuyến tiền liệt đang tìm kiếm người tham gia tại các cơ sở ở Boston và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Prostate Cancer Genetic Risk Evaluation and Screening Study
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital, Boston
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Đang tuyểnGiai đoạn 4
- Massachusetts General Hospital, Boston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Đang tuyển
- Dana-Farber Cancer Institute, Boston
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Dana Farber Mass General Brigham Cancer Care Inc, Boston
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Dana-Farber Cancer Institute, Boston
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Đang tuyểnGiai đoạn 3
- Beth Israel Deaconess Medical Center ( Site 0043), Boston
- Dana Farber Cancer Institute ( Site 0012), Boston
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Đang tuyểnGiai đoạn 1
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Precision-Based Genomics in Prostate Cancer
Đang tuyểnNghiên cứu quan sát
- Dana Farber Cancer Institute, Boston, MA, Boston
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1
- Mass General Hospital, Boston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Đang tuyểnGiai đoạn 3
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Research Site, Boston
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
Đang tuyểnNghiên cứu quan sát
- Massachsuetts General Hospital, Boston
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Research Site, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Đang tuyểnGiai đoạn 3
- Beth Israel Deaconess Med Center, Boston
- Dana Farber Cancer Institute, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- Research Site, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Đang tuyển
- Dana Farber Cancer Institute, Boston
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
Đang tuyển
- Dana-Farber Cancer Institute, Boston
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Harvard Medical School-Massachusetts General Hospital, Boston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Đang tuyểnGiai đoạn 2/3
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
CV CARE: CardioVascular Care in PC Patients
Đang tuyển
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
Đang tuyển
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Đang tuyển
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prostate Active Surveillance Study
Đang tuyểnNghiên cứu quan sát
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Đang tuyểnGiai đoạn 2
- Dana Farber Cancer Institute, Boston
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Đang tuyểnGiai đoạn 2
- Brigham and Women's Hospital, Boston
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Đang tuyểnGiai đoạn 2
- Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Dana-Farber Cancer Institute, Boston
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Đang tuyểnGiai đoạn 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Đang tuyển
- Dana Farber Cancer Institute, Boston
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Đang tuyểnGiai đoạn 3
- Dana-Farber Cancer Institute, Boston
Jump: MR Simulation For Radiation Therapy Master Protocol
Đang tuyển
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Đang tuyểnGiai đoạn 1
- Dana Farber Cancer Institute, Boston
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Đang tuyểnGiai đoạn 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
Đang tuyểnGiai đoạn 3
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Đang tuyểnNghiên cứu quan sát
- Dana-Farber Cancer Institute, Boston
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital, Boston
Clinical Trial of Approaches to Prostate Cancer Surgery
Đang tuyển
- Beth Israel Deaconess Medical Center (BIDMC), Boston
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Dana-Farber Cancer Institute, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- Dana Farber Cancer Institute, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- Massachusetts General Hospital, Boston
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Research Site, Boston
- Research Site, Boston
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Đang tuyểnGiai đoạn 4
- Dana Farber Cancer Institute, Boston
- Brigham and Womens Hospital, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Đang tuyểnGiai đoạn 4
- Massachussets General Hospital, Boston
MRI Guided Prostate Biopsy
Đang tuyển
- Brigham and Women's Hospital, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Đang tuyển
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Comprehensive Outcomes for After Cancer Health
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Dana Farber Cancer Institute, Boston
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Đang tuyểnNghiên cứu quan sát
- Massachusetts General Hospital, Boston
Thử nghiệm cho Ung thư tuyến tiền liệt tại các thành phố khác
- New York City, NY101 nghiên cứu
- Houston, TX73 nghiên cứu
- Los Angeles, CA64 nghiên cứu
- Seattle, WA45 nghiên cứu
- St. Louis, MO45 nghiên cứu
- Chicago, IL45 nghiên cứu
- Baltimore, MD45 nghiên cứu
- San Francisco, CA44 nghiên cứu
- Philadelphia, PA41 nghiên cứu
- Nashville, TN40 nghiên cứu
- Washington, DC39 nghiên cứu
- Dallas, TX39 nghiên cứu
Các nghiên cứu khác tại Boston
- Ung thư vú110 nghiên cứu
- Ung thư (mọi loại)90 nghiên cứu
- Ung thư phổi không tế bào nhỏ87 nghiên cứu
- Ung thư phổi63 nghiên cứu
- Ung thư đại trực tràng62 nghiên cứu
- Ung thư buồng trứng62 nghiên cứu
- Ung thư di căn61 nghiên cứu
- Ung thư nội mạc tử cung51 nghiên cứu
- Trầm cảm50 nghiên cứu
- Suy tim46 nghiên cứu
- U tủy xương đa phát45 nghiên cứu
- Bạch cầu tủy cấp44 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 15 thg 11, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.